Anna Lechanteur

1.9k total citations · 1 hit paper
56 papers, 1.5k citations indexed

About

Anna Lechanteur is a scholar working on Pharmaceutical Science, Molecular Biology and Biomedical Engineering. According to data from OpenAlex, Anna Lechanteur has authored 56 papers receiving a total of 1.5k indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Pharmaceutical Science, 15 papers in Molecular Biology and 14 papers in Biomedical Engineering. Recurrent topics in Anna Lechanteur's work include Drug Solubulity and Delivery Systems (14 papers), RNA Interference and Gene Delivery (13 papers) and 3D Printing in Biomedical Research (11 papers). Anna Lechanteur is often cited by papers focused on Drug Solubulity and Delivery Systems (14 papers), RNA Interference and Gene Delivery (13 papers) and 3D Printing in Biomedical Research (11 papers). Anna Lechanteur collaborates with scholars based in Belgium, Portugal and Burkina Faso. Anna Lechanteur's co-authors include Brigitte Évrard, Géraldine Piel, Olivier Jennotte, Bruno Sarmento, Rasmané Semdé, Denis Mottet, José das Neves, Andreia Almeida, Najeh Maissar Khalil and Rubiana Mara Mainardes and has published in prestigious journals such as SHILAP Revista de lepidopterología, Advanced Drug Delivery Reviews and Journal of Controlled Release.

In The Last Decade

Anna Lechanteur

54 papers receiving 1.5k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Pharmaceutical approaches for enhancing solubility and oral bioavailability of poorly soluble drugs

2024 58 citations Anna Lechanteur, Rasmané Semdé et al. European Journal of Pharmaceutics and Biopharmaceutics profile →

Peers

Countries citing papers authored by Anna Lechanteur

Since Specialization

Citations

This map shows the geographic impact of Anna Lechanteur's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anna Lechanteur with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anna Lechanteur more than expected).

Fields of papers citing papers by Anna Lechanteur

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anna Lechanteur. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anna Lechanteur. The network helps show where Anna Lechanteur may publish in the future.

Co-authorship network of co-authors of Anna Lechanteur

This figure shows the co-authorship network connecting the top 25 collaborators of Anna Lechanteur. A scholar is included among the top collaborators of Anna Lechanteur based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anna Lechanteur. Anna Lechanteur is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Formulation of a dry powder for inhalation combining ciclesonide and indacaterol maleate using spray drying 2025 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), (unknown), Pierre‐Yves Sacré, Eric Ziémons, Didier Cataldo, Géraldine Piel, Brigitte Évrard, Anna Lechanteur	0
2	Manufacturing softpellets using triboelectric agglomeration of fine powders on a vibrated inclined plane: Method and application to dry powder inhalion 2025 ·Powder Technology ·(unknown), (unknown), (unknown), Brigitte Évrard, Geoffroy Lumay, Anna Lechanteur	1
3	Cannabidiol and Hydroxypropyl-β-Cyclodextrin for the Development of Deflated Spherical-Shaped Inhalable Powder 2025 ·The AAPS Journal ·Bruno Gomes, (unknown), (unknown), Helena Cabral-Marques, Brigitte Évrard, Anna Lechanteur	1
4	Enhancement of inhaled micronized powder flow properties for accurate capsules filling 2024 ·Powder Technology ·(unknown), Justine Rousseau, (unknown), (unknown), Anna Lechanteur, Brigitte Évrard	5
5	Application of polyethylene glycol 8000 as plasticizer for the development of ellagic acid and Eudragit® EPO based solid dispersions using hot melt extrusion. 2024 ·SHILAP Revista de lepidopterología ·(unknown), (unknown), (unknown), (unknown), (unknown), Anna Lechanteur, Christian Damblon, Rasmané Semdé, Brigitte Évrard	3
6	An Intravenous Pharmacokinetic Study of Cannabidiol Solutions in Piglets through the Application of a Validated Ultra-High-Pressure Liquid Chromatography Coupled to Tandem Mass Spectrometry Method for the Simultaneous Quantification of CBD and Its Carboxylated Metabolite in Plasma 2024 ·Pharmaceutics ·(unknown), Olivier Jennotte, Anna Lechanteur, (unknown), (unknown), Jean‐Michel Cardot, Patrice Chiap, Brigitte Évrard	2
7	The promising role of semi-solid extrusion technology in custom drug formulation for pediatric medicine 2024 ·International Journal of Bioprinting ·(unknown), (unknown), (unknown), Anna Lechanteur, Christine Jérôme, (unknown), Stephen E. Flynn, Álvaro Goyanes, (unknown), Maxime Annereau, Luc Choisnard	11
8	Evaluation of amorphous and lipid-based formulation strategies to increase the in vivo cannabidiol bioavailability in piglets 2024 ·International Journal of Pharmaceutics ·Norbert Koch, Olivier Jennotte, (unknown), Anna Lechanteur, (unknown), Corinne Charlier, Patrice Chiap, (unknown), Brigitte Évrard	1
9	Development of 3D printed mini-waffle shapes containing hydrocortisone for children’s personalized medicine 2023 ·International Journal of Pharmaceutics ·(unknown), (unknown), (unknown), Anne‐Catherine Servais, Anna Lechanteur, Brigitte Évrard	22
10	Inhalation powder development without carrier: How to engineer ultra-flying microparticles? 2023 ·European Journal of Pharmaceutics and Biopharmaceutics ·Anna Lechanteur, (unknown), (unknown), Erwan Plougonven, Angélique Léonard, Nicolas Vandewalle, Geoffroy Lumay, Brigitte Évrard	5
11	Preformulation study for the selection of a suitable polymer for the development of ellagic acid-based solid dispersion using hot-melt extrusion 2023 ·International Journal of Pharmaceutics ·(unknown), Olivier Jennotte, (unknown), Anna Lechanteur, Pierre‐Yves Sacré, (unknown), Rasmané Semdé, Brigitte Évrard	15
12	Silicones in dermatological topical drug formulation: Overview and advances 2022 ·International Journal of Pharmaceutics ·(unknown), Anna Lechanteur, Géraldine Piel, Brigitte Évrard	9
13	Therapeutic peptides for chemotherapy: Trends and challenges for advanced delivery systems 2021 ·European Journal of Pharmaceutics and Biopharmaceutics ·(unknown), Anna Lechanteur, Marianne Fillet, Géraldine Piel	23
14	Engineered-inhaled particles: Influence of carbohydrates excipients nature on powder properties and behavior 2021 ·International Journal of Pharmaceutics ·Anna Lechanteur, Erwan Plougonven, (unknown), Geoffroy Lumay, Nicolas Vandewalle, Angélique Léonard, Brigitte Évrard	12
15	Innovative lipoplexes formulations with enhanced siRNA efficacy for cancer treatment: Where are we now? 2021 ·International Journal of Pharmaceutics ·(unknown), Anna Lechanteur, Brigitte Évrard, Géraldine Piel	25
16	Impregnation of mesoporous silica with poor aqueous soluble molecule using pressurized carbon dioxide: Is the solubility in the supercritical and subcritical phase a critical parameter? 2020 ·European Journal of Pharmaceutical Sciences ·Norbert Koch, Olivier Jennotte, Bruno Grignard, Anna Lechanteur, Brigitte Évrard	13
17	Development and characterization of lipid-polymeric nanoparticles for oral insulin delivery 2017 ·Expert Opinion on Drug Delivery ·(unknown), Anna Lechanteur, Andreia Almeida, Flávia Sousa, Eduardo Borges de Melo, (unknown), Rubiana Mara Mainardes, Najeh Maissar Khalil, Osvaldo Albuquerque Cavalcanti, Bruno Sarmento	36
18	Elucidation of the impact of cell culture conditions of Caco-2 cell monolayer on barrier integrity and intestinal permeability 2017 ·European Journal of Pharmaceutics and Biopharmaceutics ·Anna Lechanteur, Andreia Almeida, Bruno Sarmento	36
19	Mucoadhesive nanostructured polyelectrolytes complexes modulate the intestinal permeability of methotrexate 2017 ·European Journal of Pharmaceutical Sciences ·Fernanda Isadora Boni, Andreia Almeida, Anna Lechanteur, Bruno Sarmento, Beatriz Stringhetti Ferreira Cury, Maria Palmira Daflon Gremião	50
20	Freeze-dried mucoadhesive polymeric system containing pegylated lipoplexes: Towards a vaginal sustained released system for siRNA 2016 ·Journal of Controlled Release ·(unknown), George R. Dakwar, Elisa Zagato, Anna Lechanteur, Katrien Remaut, Brigitte Évrard, Kevin Braeckmans, Géraldine Piel	37

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact